Theragnostic Use of Radiolabelled Dota-Peptides in Meningioma: From Clinical Demand to Future Applications

Meningiomas account for approximately 30% of all new diagnoses of intracranial masses. The 2016 World Health Organization’s (WHO) classification currently represents the clinical standard for meningioma’s grading and prognostic stratification. However, watchful waiting is frequently the chosen treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Laudicella, Riccardo, Albano, Domenico, Annunziata, Salvatore, Calabrò, Diletta, Argiroffi, Giovanni, Abenavoli, Elisabetta, Linguanti, Flavia, Vento, Antonio, Bruno, Antonio, Alongi, Pierpaolo, Bauckneht, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826849/
https://www.ncbi.nlm.nih.gov/pubmed/31546734
http://dx.doi.org/10.3390/cancers11101412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826849/
https://www.ncbi.nlm.nih.gov/pubmed/31546734
http://dx.doi.org/10.3390/cancers11101412

Ejemplares similares